Research across Anemia
Related studies from across the Anemia family.
10 trials tracked for Fanconi Anemia: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 110 citations.
Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Established clinical evidence includes the use of Cyclophosphamide, which was evaluated in multiple trials for its effects on transplant outcomes [2, 8, 9]. Specifically, data from one study showed that 71 patients experienced Grade ≥3 regimen-related toxicity, while another cohort reported a mean IgG level of 550.6 as a measure of immune reconstitution at 100 days post-transplant 2.
Anti-thymocyte globulin is established as an intervention across several trials [4, 5, 7].
AI synthesis of 2 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Anemia family.